相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
Stephen S. Dominy et al.
SCIENCE ADVANCES (2019)
Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice
Krista J. Spiller et al.
NEUROBIOLOGY OF DISEASE (2019)
Matrix metalloproteinases and ADAMs in stroke
Joan Montaner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Functions of A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system
Hung-En Hsia et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease
Jing Zhi A. Tan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2019)
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking
Jean-Michel Paumier et al.
FASEB JOURNAL (2019)
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity
Fang Fang et al.
HUMAN MOLECULAR GENETICS (2018)
The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders
Susana Carmona et al.
LANCET NEUROLOGY (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?
Christiane Rose et al.
NEUROBIOLOGY OF AGING (2018)
Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models
Michal Izrael et al.
STEM CELL RESEARCH & THERAPY (2018)
Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease
Swati Naphade et al.
FRONTIERS IN NEUROSCIENCE (2018)
Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection (vol 99, pg 56, 2018)
William A. Eimer et al.
NEURON (2018)
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Sara Bachiller et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons
Karine Laulagnier et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease
Boris Decourt et al.
CURRENT ALZHEIMER RESEARCH (2017)
The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models
Se Hee Oh et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
α-synuclein aggregation and its modulation
Dhiman Ghosh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Astrocytes contribute to Aβ-induced blood-brain barrier damage through activation of endothelial MMP9
Simona Federica Spampinato et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory
Agostino Palmeri et al.
JOURNAL OF NEUROSCIENCE (2017)
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Chia-Chen Liu et al.
JOURNAL OF NEUROSCIENCE (2017)
Human umbilical cord plasma proteins revitalize hippocampal function in aged mice
Joseph M. Castellano et al.
NATURE (2017)
The role of peripheral immune cells in the CNS in steady state and disease
Marco Prinz et al.
NATURE NEUROSCIENCE (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease
Kevin Baranger et al.
NEUROPHARMACOLOGY (2017)
ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157
Dominik Feuerbach et al.
NEUROSCIENCE LETTERS (2017)
The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
Francesca Longhena et al.
NEURAL PLASTICITY (2017)
MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro
Kevin Baranger et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
MMP-7 cleaves amyloid β fragment peptides and copper ion inhibits the degradation
Masanari Taniguchi et al.
BIOMETALS (2017)
Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide
Jisun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
Peter Thornton et al.
EMBO MOLECULAR MEDICINE (2017)
Extracellular matrix inflammation in vascular cognitive impairment and dementia
Gary A. Rosenberg
CLINICAL SCIENCE (2017)
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease
Kevin Baranger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Role of RAGE in Alzheimer's Disease
Zhiyou Cai et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier
Steffen E. Storck et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
S100A9 Exacerbates the A beta 1-42-mediated Innate Immunity in Human THP-1 Monocytes
Kyoung A. Jhang et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis
Sighild Lemarchant et al.
MOLECULAR NEURODEGENERATION (2016)
A spectrum of exercise training reduces soluble A beta in a dose-dependent manner in a mouse model of Alzheimer's disease
Kaitlin M. Moore et al.
NEUROBIOLOGY OF DISEASE (2016)
Cerebrovascular pathology during the progression of experimental Alzheimer's disease
Patrizia Giannoni et al.
NEUROBIOLOGY OF DISEASE (2016)
ENHANCED IMMUNE RESPONSE TO MMP3 STIMULATION IN MICROGLIA EXPRESSING MUTANT HUNTINGTIN
C. Connolly et al.
NEUROSCIENCE (2016)
Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease
Deepak Kumar Vijaya Kumar et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
Florent Letronne et al.
EBIOMEDICINE (2016)
Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain
Sonia Mazzitelli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9
Yuta Morisaki et al.
SCIENTIFIC REPORTS (2016)
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
Tua Vinther-Jensen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model
Kuo-Hsuan Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A1-42 oligomer-induced leakage in an invitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins
Wenbin Wan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Michael Willem et al.
NATURE (2015)
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin
Elena Zenaro et al.
NATURE MEDICINE (2015)
Iron accumulation promotes TACE-mediated TNF-alpha secretion and neurodegeneration in a mouse model of ALS
Jae Keun Lee et al.
NEUROBIOLOGY OF DISEASE (2015)
Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease
Mao Peng et al.
NEUROSCIENCE LETTERS (2015)
The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
Paul Saftig et al.
PROGRESS IN NEUROBIOLOGY (2015)
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2015)
Acute function of secreted amyloid precursor protein fragment APPs alpha in synaptic plasticity
Meike Hick et al.
ACTA NEUROPATHOLOGICA (2015)
Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration
Ana Rita Vaz et al.
MOLECULAR NEUROBIOLOGY (2015)
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy
T-I Hsu et al.
ONCOGENE (2015)
Elevated Plasma Angiogenesis Factors in Alzheimer's Disease
Wei Qin et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology
Beatrice Terni et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Amyotrophic Lateral Sclerosis: An Aging-Related Disease
Giancarlo Logroscino et al.
CURRENT GERIATRICS REPORTS (2015)
Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds
Flora H. Duits et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study
Josef Marksteiner et al.
EXPERIMENTAL GERONTOLOGY (2014)
Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2
Mareike Caesar et al.
GLIA (2014)
Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease
Stephane D. Girard et al.
HIPPOCAMPUS (2014)
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid
Cecilia E. Hanzel et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
Barbara Mroczko et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches
J. A. Mikulca et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
Marta Lukaszewicz-Zajac et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Regulation of Presynaptic Ca2+, Synaptic Plasticity and Contextual Fear Conditioning by a N-terminal β-Amyloid Fragment
James L. M. Lawrence et al.
JOURNAL OF NEUROSCIENCE (2014)
Membrane-Type 1 Metalloproteinase Is Upregulated in Microglia/Brain Macrophages in Neurodegenerative and Neuroinflammatory Diseases
Anika Langenfurth et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Amyloid-beta (25-35) peptide induces the release of pro-matrix metalloprotease 9 (pro-MMP-9) from human neutrophils
Cesare Achilli et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity
David J. Marchant et al.
NATURE MEDICINE (2014)
Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice
Apostolia Fragkouli et al.
NEUROBIOLOGY OF DISEASE (2014)
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Artem Kaplan et al.
NEURON (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP
Nathalie A. Py et al.
Frontiers in Aging Neuroscience (2014)
Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
Kevin Mullane et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Brain amyloid-β oligomers in ageing and Alzheimer's disease
Sylvain E. Lesne et al.
BRAIN (2013)
Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells
Adlane Ould-Yahoui et al.
CELL TRANSPLANTATION (2013)
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
Jennifer Vandooren et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Evidence for Early Cognitive Impairment Related to Frontal Cortex in the 5XFAD Mouse Model of Alzheimer's Disease
Stephane D. Girard et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Recruitment of the Mint3 Adaptor Is Necessary for Export of the Amyloid Precursor Protein (APP) from the Golgi Complex
Amanda H. Caster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Lewy Body in Parkinson's Disease and Related Neurodegenerative Disorders
Koichi Wakabayashi et al.
MOLECULAR NEUROBIOLOGY (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
Young Cheul Chung et al.
MEDIATORS OF INFLAMMATION (2013)
Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer's Disease: Dissociation between Somatosensory Cortex and Hippocampus
Nadine Crouzin et al.
PLOS ONE (2013)
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders
Yoon-Seong Kim et al.
BIOMOLECULES & THERAPEUTICS (2012)
α-Secretase in Alzheimer's Disease and Beyond: Mechanistic, Regulation and Function in the Shedding of Membrane Proteins
Bruno Vincent et al.
CURRENT ALZHEIMER RESEARCH (2012)
Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
Ji Hae Seo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation
G. Nuebling et al.
EXPERIMENTAL NEUROLOGY (2012)
Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16
Amanda E. Starr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes
Jacob M. Basak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Functions of Aß, sAPPa and sAPPß: similarities and differences
Stephanie Chasseigneaux et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1
Lisa A. Ridnour et al.
JOURNAL OF NEUROCHEMISTRY (2012)
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin
Valentina Lo Sardo et al.
NATURE NEUROSCIENCE (2012)
Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory
Daniela Puzzo et al.
NEUROBIOLOGY OF AGING (2012)
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A beta aggregation in the 5XFAD mouse model of Alzheimer's disease
Sadim Jawhar et al.
NEUROBIOLOGY OF AGING (2012)
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
Joshua M. Milber et al.
NEUROLOGY (2012)
Regulation of Progranulin Expression in Human Microglia and Proteolysis of Progranulin by Matrix Metalloproteinase-12 (MMP-12)
Hyeon-Sook Suh et al.
PLOS ONE (2012)
Induction of RAGE Shedding by Activation of G Protein-Coupled Receptors
Verena V. Metz et al.
PLOS ONE (2012)
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis
Joseph M. Castellano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
DJ-1 Cleavage by Matrix Metalloproteinase 3 Mediates Oxidative Stress-Induced Dopaminergic Cell Death
Dong-Hee Choi et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function
Charlotte Selvais et al.
FASEB JOURNAL (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
Dong-Hee Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease
J. Duran-Vilaregut et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2010)
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
I. Niebroj-Dobosz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
Solveig Horstmann et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-β E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
Eun-Jung Lee et al.
JOURNAL OF IMMUNOLOGY (2010)
Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?
Santiago Rivera et al.
JOURNAL OF NEUROSCIENCE (2010)
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Ellen Jorissen et al.
JOURNAL OF NEUROSCIENCE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice
Cynthia P. W. Soon et al.
NEUROMUSCULAR DISORDERS (2010)
Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
John P. Miller et al.
NEURON (2010)
The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells
So-Young Kim et al.
NEUROSCIENCE LETTERS (2010)
Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells
So Hyun Joo et al.
NEUROSCIENCE LETTERS (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Stephanie J. Soscia et al.
PLOS ONE (2010)
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Erik Stomrud et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCδ-mediated signaling in MCF-7 human breast cancer cells
Sun Kyu Park et al.
CARCINOGENESIS (2009)
Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases
Johannes Levin et al.
EXPERIMENTAL NEUROLOGY (2009)
Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-Brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
Laura B. Jaeger et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2
Yang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice
Monica Garcia-Alloza et al.
JOURNAL OF NEUROCHEMISTRY (2009)
α-Synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP
Seonghan Kim et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuronal TIMP-1 Release Accompanies Astrocytic MMP-9 Secretion and Enhances Astrocyte Proliferation Induced by β-Amyloid 25-35 Fragment
Mar Hernandez-Guillamon et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Linking neuron and skin: Matrix metalloproteinases in amyotrophic lateral sclerosis (ALS)
Lubin Fang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
LRP1 shedding in human brain: roles of ADAM10 and ADAM17
Qiang Liu et al.
MOLECULAR NEURODEGENERATION (2009)
Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
Efrat Abramov et al.
NATURE NEUROSCIENCE (2009)
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
Ryoichi Kimura et al.
NEUROBIOLOGY OF DISEASE (2009)
Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
Jungsu Kim et al.
NEURON (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons
Adlane Ould-yahoui et al.
PLOS ONE (2009)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2008)
Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: Dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding
Georgina S. Butler et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tissue inhibitor of metalloproteinases-3 (TIMP-3) expression is increased during serum deprivation-induced neuronal apoptosis in vitro and in the G93A mouse model of amyotrophic lateral sclerosis:: A potential modulator of Fas-mediated apoptosis
Jae Keun Lee et al.
NEUROBIOLOGY OF DISEASE (2008)
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Stefan Lorenzl et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis
Hyang-Sook Hoe et al.
JOURNAL OF NEUROSCIENCE (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei et al.
EXPERIMENTAL NEUROLOGY (2007)
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
Yoon Seong Kim et al.
FASEB JOURNAL (2007)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease
Travis Dunckley et al.
NEUROBIOLOGY OF AGING (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes (vol 79, pg 596, 2006)
Douglas G. Walker et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice
Stefan Lorenzl et al.
EXPERIMENTAL NEUROLOGY (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes
Douglas G. Walker et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Cleavage of amyloid-β precursor protein (APP) by membrane-type matrix metalloproteinases
M Ahmad et al.
JOURNAL OF BIOCHEMISTRY (2006)
Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study -: art. no. 68
C Ogier et al.
BMC NEUROSCIENCE (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia
YS Kim et al.
JOURNAL OF NEUROSCIENCE (2005)
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis
M Dewil et al.
NEUROREPORT (2005)
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease
E Hermel et al.
CELL DEATH AND DIFFERENTIATION (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Absence of mechanical allodynia and Aβ-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase
K Komori et al.
FEBS LETTERS (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation
S Shendelman et al.
PLOS BIOLOGY (2004)
Protease degradomics:: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors
CM Overall et al.
BIOLOGICAL CHEMISTRY (2004)
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
S Lorenzl et al.
NEUROMOLECULAR MEDICINE (2004)
Inhibition of calpain cleavage of huntingtin reduces toxicity - Accumulation of calpain/caspase fragments in the nucleus
J Gafni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV
P Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system
DW Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate
J Jourquin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease
S Lorenzl et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Novel processing of β-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A
S Higashi et al.
BIOCHEMISTRY (2003)
Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells
SS Jung et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease
S Lorenzl et al.
EXPERIMENTAL NEUROLOGY (2002)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA
OP Rahkonen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
TT Ding et al.
BIOCHEMISTRY (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity
T Uekita et al.
JOURNAL OF CELL BIOLOGY (2001)
Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum
Y Sekine-Aizawa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis
W Beuche et al.
NEUROREPORT (2000)
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
A Leake et al.
NEUROSCIENCE LETTERS (2000)
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
CL Wellington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3
A Amour et al.
FEBS LETTERS (2000)
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
Y Yoshiyama et al.
ACTA NEUROPATHOLOGICA (2000)
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice
VC Wheeler et al.
HUMAN MOLECULAR GENETICS (2000)
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
S Kanda et al.
NEUROSCIENCE (2000)
分享论文
